The rise and fall of drug-eluting stents: time trend analysis in 13,647 consecutive patients undergoing percutaneous coronary intervention

Comment

David Austin et al. Am Heart J. 2007 Nov.

. 2007 Nov;154(5):e37; author reply e39.

doi: 10.1016/j.ahj.2007.07.053. Epub 2007 Sep 14.

No abstract available

Comment on

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G. Pasceri V, et al. Am Heart J. 2007 May;153(5):749-54. doi: 10.1016/j.ahj.2007.02.016. Am Heart J. 2007. PMID: 17452148 Review.

Balloon alignment T-stenting for bifurcation coronary artery disease using the sirolimus-eluting stent.
Rizik DG, Dowler DA, Villegas BJ. Rizik DG, et al. J Invasive Cardiol. 2005 Aug;17(8):437-9. J Invasive Cardiol. 2005. PMID: 16079451 No abstract available.
Drug-eluting stents. The third revolution in percutaneous coronary intervention.
Saia F, Marzocchi A, Serruys PW. Saia F, et al. Ital Heart J. 2005 Apr;6(4):289-303. Ital Heart J. 2005. PMID: 15902927 Review.
Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data).
Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Bavry AA, et al. Am J Cardiol. 2005 Jun 15;95(12):1469-72. doi: 10.1016/j.amjcard.2005.02.015. Am J Cardiol. 2005. PMID: 15950574
Impact and temporal trends of percutaneous coronary intervention in the drug-eluting stent versus bare metal stent eras.
Thompson CA, Kaplan AV, Jayne JE, Friedman BJ, Hettleman BD, Niles NW, Robb JF. Thompson CA, et al. Am J Cardiol. 2005 Sep 1;96(5):668-72. doi: 10.1016/j.amjcard.2005.04.041. Am J Cardiol. 2005. PMID: 16125492
Heparin-coated stents.
Kocsis JF, Llanos G, Holmer E. Kocsis JF, et al. J Long Term Eff Med Implants. 2000;10(1-2):19-45. doi: 10.1615/jlongtermeffmedimplants.v10.i12.50. J Long Term Eff Med Implants. 2000. PMID: 10947628 Review.